Registration Dossier

Administrative data

Description of key information

E131 Patent blue V is non carcinogenic.

Key value for chemical safety assessment

Additional information

A chronic and a long-term toxicity in vivo studies on E131 Patent blue V administered orally showed no signs of carcinogenity.

No abnormal histopathological findings or sarcomas at the site of injection were observed.

Justification for classification or non-classification

Not classified for carcinogenicity according to the CLP Regulation (EC.1272/2008). For justification see additional information.